2019
DOI: 10.1038/s41598-019-43047-3
|View full text |Cite
|
Sign up to set email alerts
|

Chemovirotherapeutic Treatment Using Camptothecin Enhances Oncolytic Measles Virus-Mediated Killing of Breast Cancer Cells

Abstract: Oncolytic virotherapy represents an emerging development in anticancer therapy. Although it has been tested against a variety of cancers, including breast cancer, the efficacy of oncolytic viral vectors delivered as a monotherapy is limited. Enhancing viral oncolytic therapies through combination treatment with anticancer agents is a feasible strategy. In this study, we considered a chemovirotherapeutic approach for treating breast adenocarcinoma using oncolytic measles virus (MV) and the chemotherapeutic agen… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
13
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(14 citation statements)
references
References 54 publications
1
13
0
Order By: Relevance
“…An increase in the number of neutrophils and the activation of the phagocytic cells also reported with V. Album[354]. Apoptosis was induced by the activation of its mitochondrial pathway [combined with oncolytic measles virus found to elicit the same therapeutic effect as high doses of camptothecin in breast adenocarcinoma[356].…”
supporting
confidence: 54%
“…An increase in the number of neutrophils and the activation of the phagocytic cells also reported with V. Album[354]. Apoptosis was induced by the activation of its mitochondrial pathway [combined with oncolytic measles virus found to elicit the same therapeutic effect as high doses of camptothecin in breast adenocarcinoma[356].…”
supporting
confidence: 54%
“…Among the different approaches that are currently being considered and despite their limited efficacy when delivered as a monotherapy [99], oncolytic viruses have demonstrated their safety [100] and ability in targeting and killing cancer cells as well as in stimulating immunotherapeutic effects in patients [101], positioning themselves as a promising strategy to increase treatment efficacy when used in combination therapy [99][100][101] and as a unique platform for personalized treatment of patients with advanced breast cancer [101].…”
Section: Where To Gomentioning
confidence: 99%
“…To avoid this bias, we used anticancer drug, the natural compound camptothecin (CPT) found in the Chinese ornamental tree, Camptotheca acuminata. CPT is known to exhibit anticancer activity in various cancer cells [42][43][44]. In this study, we checked the effect of ectopic wild-type p53 on CPT-induced cell death in p53-null HCT116 cells.…”
Section: Discussionmentioning
confidence: 99%